Santen Pharmaceutical Co stock forecast
Santen Pharmaceutical Co (SZD) Stock Forecast & Price Target
SZD Analyst Ratings
SZD Stock 12 Month Forecast
Detailed List of Analyst Forecasts​
Best Analysts Covering Santen Pharmaceutical Co
Copying DeepSeek Drug Manufacturers - General's trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +6.80% per trade.
Copying DeepSeek Drug Manufacturers - General's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +7.20% per trade.
Copying DeepSeek Drug Manufacturers - General's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +7.20% per trade.
SZD Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 1 | 1 | 0 | 0 |
In the current month, SZD has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SZD average Analyst price target in the past 3 months is ―.
SZD Financial Forecast
SZD Earnings Forecast
Next quarter’s earnings estimate for SZD is EUR 0.21 with a range of EUR 0.20 to EUR 0.23. The previous quarter’s EPS was EUR 0.14. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
SZD Sales Forecast
Next quarter’s sales forecast for SZD is EUR 434.78M with a range of EUR 428.75M to EUR 442.32M. The previous quarter’s sales results were EUR 418.83M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
